Dorothea Nagel

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy
    Yvonne Nadine Fahmueller
    Institute of Clinical Chemistry, University Hospital, Munich Grosshadern, Germany
    BMC Cancer 12:5. 2012
  2. ncbi Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
    Nikolaus Kohles
    Institute of Clinical Chemistry, University Hospital Munich Grosshadern, Germany
    BMC Cancer 11:202. 2011
  3. ncbi Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments
    Susanne Mueller
    Institute of Clinical Chemistry, University Hospital Munich Grosshadern, Marchioninistr, 15, D 81377 Munich, Germany
    BMC Cancer 6:143. 2006

Detail Information

Publications3

  1. ncbi Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy
    Yvonne Nadine Fahmueller
    Institute of Clinical Chemistry, University Hospital, Munich Grosshadern, Germany
    BMC Cancer 12:5. 2012
    ..Markers for prediction of therapy response and prognosis are needed for the individual management of those patients undergoing SIRT...
  2. ncbi Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients
    Nikolaus Kohles
    Institute of Clinical Chemistry, University Hospital Munich Grosshadern, Germany
    BMC Cancer 11:202. 2011
    ..Transarterial chemoembolization (TACE) therapy is an effective locoregional treatment in hepatocellular cancer (HCC) patients. For early modification of therapy, markers predicting therapy response are urgently required...
  3. ncbi Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments
    Susanne Mueller
    Institute of Clinical Chemistry, University Hospital Munich Grosshadern, Marchioninistr, 15, D 81377 Munich, Germany
    BMC Cancer 6:143. 2006
    ..Elevated levels of nucleosomal DNA fragments can be detected in plasma and sera of patients with malignant diseases...